|
1
|
Cameron MC, Lee E, Hibler BP, Barker CA,
Mori S, Cordova M, Nehal KS and Rossi AM: Basal cell carcinoma:
Epidemiology; pathophysiology; clinical and histological subtypes;
and disease associations. J Am Acad Dermatol. 80:303–317.
2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Matsui Y, Makino T, Takemoto K, Kagoyama K
and Shimizu T: Co-existence of basal cell carcinoma and squamous
cell carcinoma in a single burn scar region. Burns Open. 4:64–66.
2020.
|
|
3
|
Lai K, Chan E and Ko SC: Combination of
squamous cell carcinoma and basal cell carcinoma arising from a
giant verruca vulgaris involving the eyelid. Am J Ophthalmol Case
Rep. 21(100858)2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Rebegea LF, Firescu D, Dumitru M and
Patrascu A: Skin spiradenocarcinoma-case presentation. Rom J
Morphol Embryol. 57:327–330. 2016.PubMed/NCBI
|
|
5
|
Messina J, Epstein EH Jr, Kossard S,
McKenzie C, Patel RM, Patterson JW and Scolyer RA: Chapter
1-Keratinocytic/epidermal tumors. Basal cell carcinoma. In: WHO
Classification of skin tumors. Elder DE, Massi D, Scolyer RA and
Willemze R (eds). 4th edition. International Agency for Research on
Cancer, Lyon, pp26-24, 2017.
|
|
6
|
Rebegea L, Firescu D, Baciu G and Ciubara
A: Psycho-oncology support. Brain. 10:77–88. 2019.
|
|
7
|
Hogue L and Harvey VM: Basal cell
carcinoma, squamous cell carcinoma, and cutaneous melanoma in skin
of color patients. Dermatol Clin. 37:519–526. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Poignet B, Gardrat S, Dendale R, Lemaitre
S, Lumbroso-Le Rouic L, Desjardins L, Cassoux N and Levy Gabriel C:
Basal cell carcinomas of the eyelid: Results of an initial surgical
management. J Fr Ophtalmol. 42:1094–1099. 2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Kim DP, Kus KJB and Ruiz E: Basal cell
carcinoma review. Hematol Oncol Clin North Am. 33:13–24.
2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Ashraf DC, Kalin-Hajdu E, Levin MH and
Kersten RC: Mixed cranial neuropathies due to occult perineural
invasion of basal cell carcinoma. Am J Ophthalmol Case Rep.
13:136–139. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Muzumdar S, Stewart CL and Feng H: Rare
case of a basal cell carcinoma with intravascular invasion. Int J
Womens Dermatol. 6:334–335. 2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Fania L, Didona D, Morese R, Campana I,
Coco V, Di Pietro FR, Ricci F, Pallotta S, Candi E, Abeni D and
Dellambra E: Basal cell carcinoma: From pathophysiology to novel
therapeutic approaches. Biomedicines. 8(449)2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Nicoara M, Bain K, Patel R, Jaikaran O,
Hingorani A and Asher E: Malignant transformation of nonhealing
ulcer-basal cell carcinoma. Ann Vasc Surg. 70:565.e7–565.e10.
2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Coulombe C, Gagnon LP, Larouche V and
Dionne MC: Infantile-onset palmo-plantar basal cell carcinomas and
pits in Gorlin syndrome. JAAD Case Rep. 4:662–664. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Nwabudike LC and Tatu AL: Response
to-Chronic exposure to tetracyclines and subsequent diagnosis for
non-melanoma skin cancer in a large Mid-Western US population. J
Eur Acad Dermatol Venereol. 32(e159)2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Tatu AL, Ciobotaru OR, Miulescu M, Buzia
OD, Elisei AM, Mardare N, Diaconu C, Robu S and Nwabudike LC:
Hydrochlorothiazide: Chemical structure, therapeutic, phototoxic
and carcinogenetic effects in dermatology. Rev Chim (Bucharest).
69:2110–2114. 2018.
|
|
17
|
Nwabudike LC, Elisei AM, Buzia OD,
Miulescu M and Tatu AL: Statins. A review on structural
perspectives, adverse reactions and relations with non-melanoma
skin cancer Rev Chim. (Bucharest). 69:2557–2562. 2018.
|
|
18
|
Draganescu M, Baroiu L, Iancu A, Dumitru
C, Radaschin D, Polea ED, Bobeica C, Tatu AL, Niculet E and Fekete
GL: Perspectives on skin disorder diagnosis among people living
with HIV in southeastern Romania. Exp Ther Med.
21(97)2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Niculet E, Chioncel V, Elisei AM, Miulescu
M, Buzia OD, Nwabudike LC, Craescu M, Draganescu M, Bujoreanu F,
Marinescu E, et al: Multifactorial expression of IL-6 with update
on COVID-19 and the therapeutic strategies of its blockade
(Review). Exp Ther Med. 21(263)2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Jee SH, Shen SC, Chiu HC, Tsai WL and Kuo
ML: Overexpression of interleukin-6 in human basal cell carcinoma
cell lines increases anti-apoptotic activity and tumorigenic
potency. Oncogene. 20:198–208. 2001.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Lupu M, Caruntu A, Caruntu C, Papagheorghe
LML, Ilie MA, Voiculescu V, Boda D, Constantin C, Tanase C, Sifaki
M, et al: Neuroendocrine factors: The missing link in non melanoma
skin cancer (Review). Oncol Rep. 38:1327–1340. 2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
McEnery-Stonelake ME, Clark MA and Vidimos
AT: Vulvar basal cell carcinoma arising in the setting of repeated
perilamp exposure. JAAD Case Rep. 6:103–105. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Varadarajan VV, Nasri E and Dziegielewski
PT: Basal cell carcinoma of the oral cavity: A case report.
Otolaryngol Case Rep. 15(100159)2020.
|
|
24
|
Tatu AL and Nwabudike LC: The treatment
options of male genital lichen sclerosus et atrophicus short title
for a running head: Treatments of genital lichen sclerosus. In:
Proceedings of the 14th National Congress of Urogynecology and the
National Conference of the Romanian Association for the Study of
Pain, pp262-264, 2017.
|
|
25
|
Rustemeyer J, Günther L and Deichert L: A
rare association: Basal cell carcinoma in a vitiliginous macula.
Oral Maxillofac Surg. 15:175–177. 2011.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Mihăilă B, Dinică RM, Tatu AL and Buzia
OD: New insights in vitiligo treatments using bioactive compounds
from Piper nigrum. Exp Ther Med. 17:1039–1044. 2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Fiszon-Cerqueira L, Ramos-E-Silva M,
Guerreiro FB, Cistaro-Serrano M, Carneiro AHC and Gomes MK: Giant
basal cell carcinoma associated with vitiligo. Clin Case Rep.
7:1782–1786. 2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Byrne KT and Turk MJ: New perspectives on
the role of vitiligo in immune responses to melanoma. Oncotarget.
2:684–694. 2011.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Nwabudike LC, Tebeica T and Tatu AL:
Nodular, ulcerated seborrheic keratosis. Clin Exp Dermatol.
45:602–604. 2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Tatu AL: Umbilicated blue black lesion on
the lateral thorax. J Cutan Med Surg. 21(252)2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Earar K, Sirbu I, Onisor C and Luca E:
Oral rehabilitation on implants and introduction of pathogenic
mechanisms in relation to oral implants-sugar diabetes. Rev Chim
(Bucharest). 70:3750–3752. 2019.
|
|
32
|
Lupu M, Caruntu C, Popa MI, Voiculescu VM,
Zurac S and Boda D: Vascular patterns in basal cell carcinoma:
Dermoscopic, confocal and histopathological perspectives. Oncol
Lett. 17:4112–4125. 2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Căruntu C, Boda D, Guţu DE and Căruntu A:
In vivo reflectance confocal microscopy of basal cell carcinoma
with cystic degeneration. Rom J Morphol Embryol. 55:1437–1441.
2014.PubMed/NCBI
|
|
34
|
Mackiewicz-Wysocka M, Bowszyc-Dmochowska
M, Strzelecka-Węklar D, Dańczak-Pazdrowska A and Adamski Z: Basal
cell carcinoma-diagnosis. Contemp Oncol (Pozn). 17:337–342.
2013.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Dourmishev LA, Rusinova D and Botev I:
Clinical variants, stages, and management of basal cell carcinoma.
Indian Dermatol Online J. 4:12–17. 2013.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Lima NL, Verli FD, de Miranda JL and
Marinho SA: Basosquamous carcinoma: Histopathological features.
Indian J Dermatol. 57:382–383. 2012.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Abudu B and Cohen PR: Pigmented basal cell
carcinoma masquerading as a melanoma. Cureus.
11(e4369)2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Shash HA, Almarzouq SF, Alghamdi AA and
Alratroot JA: Basal cell carcinoma with sebaceous differentiation:
A case report and review of literature. Plast Reconstr Surg Glob
Open. 8(e3234)2020.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Haddock ES and Cohen PR: Fibroepithelioma
of pinkus revisited. Dermatol Ther (Heidelb). 6:347–362.
2016.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Reiter O, Mimouni I, Gdalevich M, Marghoob
AA, Levi A, Hodak E and Leshem YA: The diagnostic accuracy of
dermoscopy for basal cell carcinoma: A systematic review and
meta-analysis. J Am Acad Dermatol. 80:1380–1388. 2019.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Reiter O, Mimouni I, Dusza S, Halpern AC,
Leshem YA and Marghoob AA: Dermoscopic features of basal cell
carcinoma and its subtypes: A systematic review. J Am Acad
Dermatol. 85:653–664. 2019.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Álvarez-Salafranca M, Ara M and Zaballos
P: Dermoscopy in basal cell carcinoma: An updated review. Actas
Dermosifiliogr. 112:330–338. 2021.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Cameron MC, Lee E, Hibler BP, Giordano CN,
Barker CA, Mori S, Cordova M, Nehal KS and Rossi AM: Basal cell
carcinoma: Contemporary approaches to diagnosis, treatment, and
prevention. J Am Acad Dermatol. 80:321–339. 2019.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Suppa M, Fontaine M, Dejonckheere G,
Cinotti E, Yélamos O, Diet G, Tognetti L, Miyamoto M, Orte Cano C,
Perez-Anker J, et al: Line-field confocal optical coherence
tomography of basal cell carcinoma: A descriptive study. J Eur Acad
Dermatol Venereol. 35:1099–1110. 2021.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Holmes J, von Braunmühl T, Berking C,
Sattler E, Ulrich M, Reinhold U, Kurzen H, Dirschka T, Kellner C,
Schuh S and Welzel J: Optical coherence tomography of basal cell
carcinoma: Influence of location, subtype, observer variability and
image quality on diagnostic performance. Br J Dermatol.
178:1102–1110. 2018.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Hussain AA, Themstrup L and Jemec GB:
Optical coherence tomography in the diagnosis of basal cell
carcinoma. Arch Dermatol Res. 307:1–10. 2015.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Lupu M, Popa IM, Voiculescu VM, Boda D,
Caruntu C, Zurac S and Giurcaneanu C: A retrospective study of the
diagnostic accuracy of in vivo reflectance confocal microscopy for
basal cell carcinoma diagnosis and subtyping. J Clin Med.
8(449)2019.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Ghita MA, Caruntu C, Rosca AE, Kaleshi H,
Caruntu A, Moraru L, Docea AO, Zurac S, Boda D, Neagu M, et al:
Reflectance confocal microscopy and dermoscopy for in vivo,
non-invasive skin imaging of superficial basal cell carcinoma.
Oncol Lett. 11:3019–3024. 2016.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Sahu A, Yélamos O, Iftimia N, Cordova M,
Alessi-Fox C, Gill M, Maguluri G, Dusza SW, Navarrete-Dechent C,
González S, et al: Evaluation of a combined reflectance confocal
microscopy-optical coherence tomography device for detection and
depth assessment of basal cell carcinoma. JAMA Dermatol.
154:1175–1183. 2018.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Reddy N and Nguyen BT: The utility of
optical coherence tomography for diagnosis of basal cell carcinoma:
A quantitative review. Br J Dermatol. 180:475–483. 2019.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Navarrete-Dechent C, Rajadhyaksha M and
Nehal KS: Can optical coherence tomography improve the management
of basal cell carcinoma? Br J Dermatol. 180:448–449.
2019.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Wang SQ, Liu J, Zhu QL, Zhao CY, Qu T, Li
F, Wortsman X and Jin HZ: High-frequency ultrasound features of
basal cell carcinoma and its association with histological
recurrence risk. Chin Med J (Engl). 132:2021–2026. 2019.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Bobadilla F, Wortsman X, Muñoz C, Segovia
L, Espinoza M and Jemec GB: Pre-surgical high resolution ultrasound
of facial basal cell carcinoma: Correlation with histology. Cancer
Imaging. 8:163–172. 2008.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Wallace VP, Fitzgerald AJ, Pickwell E, Pye
RJ, Taday PF, Flanagan N and Ha T: Terahertz pulsed spectroscopy of
human Basal cell carcinoma. Appl Spectrosc. 60:1127–1133.
2006.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Woodward RM, Cole B, Wallace VP, Arnone
DD, Pye R, Linfield EH, Pepper M and Davies AG: Terahertz pulse
imaging of in-vitro basal cell carcinoma samples. Technical Digest.
Summaries of papers presented at the Conference on Lasers and
Electro-Optics. Postconference Technical Digest (IEEE Cat. No.
01CH37170), 329-330, 2001.
|
|
56
|
Zhang J, Fan Y, Song Y and Xu J: Accuracy
of Raman spectroscopy for differentiating skin cancer from normal
tissue. Medicine (Baltimore). 97(e12022)2018.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Ilie MA, Caruntu C, Lixandru D, Tampa M,
Georgescu SR, Constantin MM, Constantin C, Neagu M, Zurac SA and
Boda D: In vivo confocal laser scanning microscopy imaging
of skin inflammation: Clinical applications and research directions
(Review). Exp Ther Med. 17:1004–1011. 2019.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Cerci FB, Kubo EM and Werner B: Comparison
of basal cell carcinoma subtypes observed in preoperative biopsy
and Mohs micrographic surgery. An Bras Dermatol. 95:594–601.
2020.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Kopf AW, Bart RS, Schrager D, Lazar M and
Popkin GL: Curettage-electrodesiccation treatment of basal cell
carcinomas. Arch Dermatol. 113:439–443. 1977.PubMed/NCBI
|
|
60
|
Li X, Tan L, Kou H, Zhang J, Wang Y, Li G
and Lu Y: Ocular preservation through limited tumor excision
combined with ALA-PDT in patients with periocular basal cell
carcinoma. Photodiagnosis Photodyn Ther. 27:291–294.
2019.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Williams HC, Bath-Hextall F, Ozolins M,
Armstrong SJ, Colver GB, Perkins W and Miller PSJ: Surgery versus
imiquimod for nodular and superficial basal cell carcinoma (SINS)
study group. surgery versus 5% imiquimod for nodular and
superficial basal cell carcinoma: 5-year results of the SINS
randomized controlled trial. J Invest Dermatol. 137:614–619.
2017.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Sabu DM, Kroes J, Gilham C, Fleming A and
Kelleher FC: Neo-adjuvant Vismodegib followed by radiation in
locally advanced basal cell carcinoma. Curr Probl Cancer: Apr 1,
2021 (Epub ahead of print).
|
|
63
|
Chanu P, Musib L, Wang X, Cheeti S, Girish
S, Bruno R, Lu T, Reddy J, Jin JY and Caro I: Vismodegib efficacy
in advanced basal cell carcinoma maintained with 8-week dose
interruptions: A model-based evaluation. J Invest Dermatol.
141:930–933. 2021.PubMed/NCBI View Article : Google Scholar
|
